Home > Insider Trading > Pacira Biosciences Inc.

Pacira Biosciences Inc. (PCRX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
41 - 50
Next >>

Should You Buy Pacira Pharmaceuticals Inc (PCRX)?

It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...

Keep Reading →

November 29th, 2015 - Hedge Funds News

A Look at 5 Major Stock Market Gainers and the Drivers Behind Their Sharp Uptrend

As stock markets are trading in a narrow range with a slight negative bias today, five stocks are showing significant upside price movement backed by high volumes.

Keep Reading →

October 27th, 2015 - Earnings Report News

Four Hot Biotechs Among The Day’s Big Winners

On a day when Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is deep in the red following the release of its third quarter earnings, four other biotech stocks are making strong gains.

Keep Reading →

October 19th, 2015 - Market Movers News

Goldman Sachs And Hedge Funds See Big Things For These Small-caps

The recent pull back in the Russell 2000 index left it down about 10% on a year-to-date basis just before the start of this month.

Keep Reading →

October 16th, 2015 - News

What Hedge Funds Think Of Goldman Sachs' Top Healthcare Takeover Targets

A surge of M&A activity involving healthcare, financial, and retail companies boosted the value of deals in July to over $430 billion, resulting in the seventh-busiest month on record in terms of value...

Keep Reading →

September 12th, 2015 - Hedge Funds Market Movers News

Baker Bros. Advisors Buys More DBV Technologies S.A. (DBVT); Visium Asset Management Goes Long On Pacira Pharmaceuticals Inc. (PCRX)

According to a freshly-amended 13G filing with the SEC, Baker Bros. Advisors LP, founded by Julian Baker and Felix Baker, revealed it owns 15.1% of DBV Technologies S.A.

Keep Reading →

August 11th, 2015 - Hedge Funds News

Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?

To the average investor, there are many methods market participants can use to analyze publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading activity.

Keep Reading →

September 17th, 2013 - News

This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)

In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.

Keep Reading →

September 4th, 2013 - News

Hedge Funds Are Buying Impax Laboratories Inc (IPXL)

At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies. A couple of the most under-the-radar are hedge fund and insider trading interest.

Keep Reading →

September 3rd, 2013 - News

Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?

To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading interest.

Keep Reading →

August 26th, 2013 - News